16:01 EST 60 Degrees Pharmaceuticals files to sell 4.79M units
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SXTP:
- 60 Degrees Pharmaceuticals regains compliance with Nasdaq listing rules
- H.C. Wainwright sees larger opportunity for 60 Degrees’ Arakoda in babesiosis
- 60 Degrees reports IRB approval of Phase IIA study of tafenoquine
- 60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024